Roderick N Carter Selected Research

Thiosulfate Sulfurtransferase (Rhodanese)

11/2021	The hepatic compensatory response to elevated systemic sulfide promotes diabetes.
4/2018	Corrigendum: Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness.
1/2016	Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roderick N Carter Research Topics

Disease

4	Obesity 01/2023 - 01/2016
3	Insulin Resistance 07/2017 - 01/2014
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 11/2021
2	Type 2 Diabetes Mellitus (MODY) 11/2021 - 07/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2014
2	Thinness 04/2018 - 01/2016
1	Progeria (Hutchinson Gilford Syndrome) 01/2023
1	Weight Gain 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Lipodystrophy 01/2022
1	Adenocarcinoma 01/2022
1	Hypertrophy 01/2022
1	Fatty Liver 11/2021
1	Hypertriglyceridemia 11/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Retinal Degeneration 12/2018
1	Late-Onset Retinal Degeneration 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2017
1	Hypertension (High Blood Pressure) 07/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2017
1	Leukemia 01/2017
1	Hyperglycemia 01/2014
1	Cognitive Dysfunction 05/2010
1	Mood Disorders (Mood Disorder) 07/2009
1	Feeding and Eating Disorders (Eating Disorder) 07/2009
1	Anxiety Disorders (Anxiety Disorder) 07/2009

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
3	Thiosulfate Sulfurtransferase (Rhodanese)IBA 11/2021 - 01/2016
3	GlucocorticoidsIBA 12/2016 - 05/2010
2	EnzymesIBA 11/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 07/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2018 - 01/2016
2	Insulin (Novolin)FDA Link 01/2016 - 01/2014
2	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 01/2014 - 05/2010
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2022
1	CopperIBA 01/2022
1	IonophoresIBA 01/2022
1	Sulfides (Thioethers)IBA 11/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2021
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2021
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	PalmitatesIBA 01/2020
1	Retinaldehyde (Retinal)IBA 12/2018
1	Triglycerides (Triacylglycerol)IBA 07/2017
1	Complement Factor B (Factor B)IBA 07/2017
1	SynucleinsIBA 01/2017
1	FumaratesIBA 01/2017
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	HydrogenIBA 01/2016
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	Antidepressive Agents (Antidepressants)IBA 07/2009
1	Anti-Anxiety Agents (Anxiolytics)IBA 07/2009
1	5-HT2C Serotonin ReceptorIBA 07/2009

Therapy/Procedure

2	Islets of Langerhans Transplantation 01/2020 - 01/2014
1	Therapeutics 01/2020